Literature DB >> 10877202

Beta-cell dysfunction in 48-hour glucose-infused rats is not a consequence of elevated plasma lipid or islet triglyceride levels.

C J de Souza1, J V Capotorto, S Cornell-Kennon, Y J Wu, G M Steil, N Trivedi, G C Weir.   

Abstract

The abnormal insulin secretion found in human diabetics and animal models of diabetes has been attributed to the deleterious effects of chronic hyperglycemia and/or elevated circulating levels of nonesterified fatty acids (NEFAs). In this study, abnormal glucose-induced insulin secretion (GIIS) was generated by a 48-hour infusion of glucose and assessed by the isolated perfused pancreas technique. In these hyperglycemic animals, abnormal GIIS is accompanied by a decrease in plasma NEFAs, while plasma and, more importantly, islet triglycerides remain at levels comparable to those in the controls. It is concluded that the abnormal insulin secretion in this glucose infusion model was likely caused by 48 hours of hyperglycemia and not by changes in circulating or islet lipids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877202     DOI: 10.1053/meta.2000.6240

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass.

Authors:  G Fontés; B Zarrouki; D K Hagman; M G Latour; M Semache; V Roskens; P C Moore; M Prentki; C J Rhodes; T L Jetton; V Poitout
Journal:  Diabetologia       Date:  2010-07-14       Impact factor: 10.122

2.  Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats.

Authors:  Rachel A Jamison; Romana Stark; Jianying Dong; Shin Yonemitsu; Dongyan Zhang; Gerald I Shulman; Richard G Kibbey
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-23       Impact factor: 4.310

3.  Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets.

Authors:  Derek K Hagman; Martin G Latour; Swarup K Chakrabarti; Ghislaine Fontes; Julie Amyot; Caroline Tremblay; Meriem Semache; James A Lausier; Violet Roskens; Raghavendra G Mirmira; Thomas L Jetton; Vincent Poitout
Journal:  Diabetes       Date:  2007-11-08       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.